Clinical Trial Update: Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer [NA]

View source ↗

Summary

Trial investigating glutamine to prevent myalgia and arthralgia in cancer patients treated with paclitaxel was terminated, and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Glutamine (glutamine)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pain, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: TERMINATED | Results posted: 2010-09-24